The utility of diuretic therapy in preventing heart failure is now well accepted and it is possible in this trial that doxazosin was not a drug that caused heart failure but rather one that simply ...
Aldosterone is an important mediator in the pathogenesis of heart failure, and increased plasma aldosterone levels are associated with a poor prognosis. Aldosterone-receptor blocking drugs can ...
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...
Aims: Non-steroidal anti-inflammatory drugs have been associated with increased risk of congestive heart failure (CHF). We aimed to assess the impact of treatment with etoricoxib or diclofenac on ...
COMET-HF (Confirmation of Omecamtiv Mecarbil Efficacy Trial in Heart Failure) is a confirmatory ... that the FDA has accepted the company’s new drug application (NDA) for lead pipeline candidate ...